UNIVERSITY OF THE FUTURE
SCIENTIFICALLY INTRODUCING UNIVERSALITY TO THE UNIVERSITY
peter huebner • micro music laboratories
M E D I C A L   R E S O N A N C E   T H E R A P Y   M U S I C®
R E D U C T I O N   O F   P S Y C H O – P H Y S I O L O G I C A L   M A N I F E S T A T I O N S   O F   S T R E S S

 




Home

Site Map

Motto

The Cosmic
Education Program

Introduction

Peter Hübner
Developer of the University

 

Faculty of
MEDICAL SCIENCES

Leading Thoughts

Logical Path - Theory

Logical Path - Practice

CURRICULUM

Theoretical Fundamentals

Medical Music
Preparations on CD

Scientific Research

Research Fields Summary

Headaches

Migraine

Sleep Disorders

Pains

Neurodermatitis

Psoriasis

Medication Consumption

Dermatology

Dispersion of Stress

Faster Recovery

Fear

Dizziness

Cardiovascular System

Hormone / Immune System

The Mental State

Operations

Radiation Sickness

ENT

Multiple Sclerosis

Gerontology

Diabetes

Cerebral & Nervous System

Mental & Sensory Abilities

Pediatrics

Pregnancy and Birth

Gynecology

Epilepsy

Concentration / Memory

Courage to Face Life

Creativity

Harmony

Mother & Child

Neurophysiological &
Sensory Disorders

Relaxation

Vital Energy

 

 

Astronomy of Mind EQ x IQ

Hall of Harmony

International Experts

Educational Program
Health

Scientific Research

International Media

International Congresses

Membership

Application to the University

 

 






Scientific Studies and Clinical Observations
PREGNANCY & BIRTH
  • Faster normalization of excessively high blood pressure in pregnant women with mild OPH syndrome than in the medication group
  • Significant reduction in the number of premature births – from 14% down to 6,2% – since the introduction of treatment with Medical Resonance Therapy Music® for pregnant women facing the risk of miscarriage
  • Faster breakdown of the protein content in the urine of pregnant women with OPH syndrome
  • Significantly better development of the kariopicnotic index in pregnant women facing the risk of miscarriage than in the control group and, as a result, a significantly better pregnancy
  • Dispersion of the clinical risk characteristics in pregnant women with a threat of miscarriage:
    after 2-3 days there were no longer any clinical risk characteristics in 60% of the women, in 100% after 5-7 days. In the control group: the clinical risk characteristics had disappeared in 70% after 7-10 days, in 30% there was no complete dispersion of the risk characteristics
  • Improvement in the foetal heart activity in pregnant women with OPH syndrome: 20 – 30% faster than in the control group
  • Significant improvement in the hormone status in pregnant women with somatic disorders leading to a significant increase in the well-being of mother and child, compared to only minor improvement in the control group
  • Taking of foetal heart activity out of the danger zone to a very satisfactory condition
  • Calming of the child inside the mother’s body during labor
  • Improvement of uterine activity: increased strength and a more harmonic rhythm of uterine contractions in women with an initial inactivity of the uterus during labor.
  • Reduction of anxiety during labor.
  • Reduction of pain during labor.
  • Reduction of hormonal manifestations of stress during labor.
  • Improvement of the general mental state in women with a mild OPH-syndrome.
  • Improvement of restless and depressive states in pregnant women with a threatening loss of pregnancy: in 69,2% of the women a total normalization of the psychic state occurred, no woman showed an aggravation of these symptoms. The results of the control group: in 40% a complete normalization, in 40% a further aggravation of the state.
  • Improvement of the immune status of pregnant women diagnosed for a threatening miscarriage: after the treatment the percentage of healthy women was 55% versus 46% in the control group.
  • Faster recovery of pregnant women with an OPH-syndrom: by 14% faster than in the control group.
  • Reducing the frequency of headache attacks in pregnant women from 73% to 20%. In the control group an increase from 60% to 70%.
  • Improvement of sleep in 77% of the pregnant women with a mild form of the OPH syndrome.
  • Improvement of sleep in 77% of the pregnant women with a mild form of the OPH syndrome. Reducing the frequency of sleep disorders from 86% to 7%. In the control group an increase from 50% to 80%.
  • Reduction of psycho-emotional stress by 47% versus no reduction in the control group.
  • Almost complete elimination of the risk factor stress in pregnant women: reducing the stress hormone cortisol by 36% while at the same time doubling the hormone progesterone.
 


  For this indication please use the program:

PREGNANCY & BIRTH
 
 
 

   If you want to look at the studies in detail, please visit: